Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats.

Docsa, Tibor

Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats. [electronic resource] - Current topics in medicinal chemistry 2015 - 2390-4 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-4294

10.2174/1568026615666150622091407 doi


Animals
Blood Glucose--analysis
Diabetes Mellitus, Experimental--blood
Glycogen--metabolism
Glycogen Phosphorylase--antagonists & inhibitors
Hypoglycemic Agents--administration & dosage
Insulin--administration & dosage
Insulin Resistance
Liver--drug effects
Male
Monosaccharides--administration & dosage
Rats, Wistar
Spiro Compounds--administration & dosage
Streptozocin